Related Experiment Video
Updated: Jun 2, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis
Purpose Of Review:
The appearance of progressive multifocal leukoencephalopathy (PML) in association with newer, highly effective biological agents has increased the importance of understanding the mechanisms by which they and other underlying predisposing causes give rise to the disorder. This review attempts to describe what is currently known about the pathogenesis of PML.
Recent Findings:
JC virus is a ubiquitous polyoma virus that infects at least 50% of the human population by adulthood. Despite this high prevalence of infection PML remains exceptionally rare, suggesting the presence of multiple high barriers to its development. Proposed barriers include host, viral, and immunological factors. With respect to host factors, no data is presently available. A viral barrier exists if the initial infection is with the archetype JC virus which requires genetic rearrangement of its promoter region to enable effective replication in oligodendrocytes. Cell-mediated immunity, in particular, JC virus-specific cytotoxic T cells, appears to be the most important recognized immunological barrier but likely not the only one.
Summary:
There remain significant gaps in our understanding of JC virus biology and PML pathogenesis. However, the present state of knowledge provides a framework for the generation of coherent and reasonable hypotheses. A better understanding of these disease mechanisms will improve our ability to both predict and mitigate the risks for the development of PML associated with various predisposing diseases and therapies.
Insights
Progressive multifocal leukoencephalopathy (PML) is rare despite widespread JC virus infection, indicating significant biological barriers. Understanding these barriers is crucial for managing PML risks associated with new therapies.
Area of Science:
- Neurovirology
- Immunology
- Pathogenesis of demyelinating diseases
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare but serious demyelinating disease.
- The increasing use of highly effective biological agents has heightened concerns regarding PML.
- Understanding PML pathogenesis is critical for risk assessment and mitigation.
Discussion:
- JC virus (JCV), a common human polyomavirus, is the causative agent of PML.
- PML development requires overcoming multiple host, viral, and immunological barriers.
- JCV requires promoter rearrangement for oligodendrocyte infection, representing a viral barrier.
Key Insights:
- Cell-mediated immunity, specifically JC virus-specific cytotoxic T cells, is a primary immunological barrier against PML.
- Despite high JCV seroprevalence, PML incidence is very low, underscoring the importance of these protective mechanisms.
- Host factors influencing PML susceptibility remain largely uncharacterized.
Outlook:
- Significant knowledge gaps persist regarding JCV biology and PML pathogenesis.
- Current understanding provides a foundation for developing predictive models and risk mitigation strategies.
- Further research into JCV-PML mechanisms will improve patient care and therapeutic safety.
More Related Videos
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
05:44Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Related Concept Videos
Encephalitis ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Cerebral Edema ll: Pathophysiology